Cardiac Ion Channel Testing Service

Detect safety issues at the early stages of drug development

In line with the currently discussed expansion of cardiac safety assessment from hERG screening to a comprehensive assessment of ion channel effects, we offer a premium panel of CiPA-compliant cardiac ion channel assays. Our safety panel includes the key cardiac channels, providing a robust, cost-effective approach to cardiac safety testing.


Our services

Our Cardiac Ion Channel Panel services as well as our “Multiwell Cardiac Screen” Assay use human cardiomyocytes to allow a greater insight into potential cardiac risks, and allow for more effective decision making in early preclinical development.

  • hERG                delayed rectifier potassium current (IKr)
  • Cav1.2               L-type calcium current (ICa)
  • Nav1.5               sodium current (INa)
  • Kir2.1                 inward rectifier potassium current (IK1)
  • KvLQT1/minK    delayed rectifier potassium current (IKs)
  • Kv4.3                 transient outward potassium current (Ito)
  • Kv1.5                 delayed rectifier potassium current (IKur)



  • Manual Patch Clamp
  • Automated Patch Clamp (Qpatch)



  • Sophion Qpatch 16X